GGrantIndex
Sort

50,496 grants matching lung cancer

Retrospective NCI Phantom-Monte Carlo Dosimetry for Late Effects in Wilms Tumor

$586,471
John Andrew Kalapurakal · Northwestern University At Chicago · R01 · FY2018 · CA

Synergizing genome sequencing with advances in patient reprted outcomes (PRO)

$586,464
Kathryn Jean Ruddy · Mayo Clinic Rochester · R01 · FY2020 · NR

The rodent eye as a non-invasive window for understanding cancer nanotherapeutics

$586,386
Kit S Lam · University Of California At Davis · U01 · FY2017 · CA

The rodent eye as a non-invasive window for understanding cancer nanotherapeutics

$586,386
Kit S Lam · University Of California At Davis · U01 · FY2016 · CA

New Therapuetics for Pancreatic Cancer

$586,363
Martin Ernesto Fernandez-Zapico · Mayo Clinic Rochester · R01 · FY2023 · CA

Development of selective HDAC6 inhibitors to improve cancer immunotherapy

$586,358
Alejandro V Villagra · George Washington University · R01 · FY2021 · CA

The Opioid Cohort Consortium (OPICO) to investigate the effects of using opioids on cancer risk

$586,334
Mahdi Sheikh · International Agency For Res On Cancer · U01 · FY2024 · CA

Engineering immunotherapeutic probiotics to mitigate irAE

$586,329
Tal Danino · Columbia Univ New York Morningside · U01 · FY2020 · CA

PET Imaging of KRAS2 Activation to Guide EGFR Targeting in Cancer Therapy

$586,293
Eric Wickstrom · Thomas Jefferson University · R01 · FY2011 · CA

FUNCTIONAL CHARACTERIZATION AND MODELING OF ACQUIRED RESISTANCE TO IMMUNE MODULATION IN LUNG CANCER

$586,246
Yale Univ · · FY2017 · Department of the Army

DISCOVERING CHECKPOINT BLOCKADE RESISTANCE GENES IN METASTATIC LUNG CANCER

$586,232
Yale Univ · · FY2017 · Department of the Army

Regulation of Ras-Dependent Signal Transduction Pathways

$586,231
Deborah Morrison · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

The UGT2A and 3A metabolizing enzymes and tobacco-related cancer risk

$586,231
Philip Lazarus · Washington State University · R01 · FY2019 · ES

Carolina Cardiopulmonary Gene Expression Services

$586,205
University Of North Carolina Chapel Hill · R01 · FY2004 · HL

Alternative Fuel Use to Reduce Diesel Emissions Exposure and Toxicity in Mining

$586,198
Jefferey L Burgess · University Of Arizona · R01 · FY2019 · OH

Aerosol Delivery of Topotecan for Personalized Lung Cancer Therapy

$586,195
Mathewos Tessema · Lovelace Biomedical & Environmental Research Institute · R01 · FY2019 · CA

Elucidating the evolution of Krt8+ alveolar cells to Kras-mutant lung preneoplasia and cancer

$586,157
Humam Kadara · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA

Precision Antibody Imaging & Radiotherapy of Solid Tumors

$586,120
Jan E Schnitzer · Proteogenomics Research Instit/Sys/ Med · P01 · FY2020 · CA

Investigating Radiation-Induced Injury to Airways and Pulmonary Vasculature in Lung SABR

$586,093
Amit Sawant · University Of Maryland Baltimore · R01 · FY2017 · CA

Regulation of tumor recurrence by stress activated neutrophils

$586,051
Rugang Zhang · Wistar Institute · R01 · FY2021 · CA

Ms. LILAC: Muscle Mass in the Life and Longevity After Cancer (LILAC) Study

$586,035
Hailey Rose Banack · State University Of New York At Buffalo · R37 · FY2025 · CA

Development of novel selective Rac inhibitors for refractory leukemias

$585,986
David A Williams · Boston Children'S Hospital · R01 · FY2020 · CA

Preoperative Respiratory Muscle Training to Prevent Postoperative Pulmonary Complications in Patients Undergoing Resection for Lung Cancer

$585,953
Andrew Donald Ray · Roswell Park Cancer Institute Corp · R01 · FY2018 · CA

Radon on the RADAR

$585,908
Ellen J Hahn · University Of Kentucky · R01 · FY2020 · ES

UCSF Project 1

$585,896
Trever G Bivona · University Of California, San Francisco · U54 · FY2019 · CA